Topical JAK inhibitors in the lichen planus spectrum: a systematic review [0.03%]
斑块型银屑病外用JAK抑制剂系统评价及meta分析
M Shanshal,A Uthayakumar
M Shanshal
Background: The lichen planus spectrum includes cutaneous, scalp, pigmentary, and nail phenotypes. Topical Janus kinase inhibitors offer targeted treatment with limited systemic exposure. ...
M Boyer,M Boyer,E Joly et al.
M Boyer et al.
Introduction: Anogenital warts (AGW) are benign epithelial skin lesions caused mainly by the human papillomavirus (HPV, types 6 and 11) but are sometimes associated with other oncogenic HPV types. They have a high rate of...
S El Lakkiss,M Battistella,C Baudry et al.
S El Lakkiss et al.
J Le Bourdon,D Canu,O Letertre et al.
J Le Bourdon et al.
Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine [0.03%]
与风疹疫苗所致肉芽肿病伴发的软骨发育不全脱发症
F-Z El Fatoiki,Y Habibi,S Machaou et al.
F-Z El Fatoiki et al.
Reflectance confocal microscopy in lentigo maligna and lentigo maligna melanoma: a state-of-the-art overview [0.03%]
关于恶性雀斑样黑色素瘤和界线性黑色素瘤的反射共聚焦显微镜：最新概述
O Mathieu,C Lebbé,M Battistella et al.
O Mathieu et al.
Depression and anxiety in visible skin diseases affecting the hands and face: a systematic literature review [0.03%]
影响手部和面部皮肤病的心理情绪障碍：系统文献回顾
A Grosperrin,C Arnal,A-C Bursztejn
A Grosperrin
Background: Visible skin diseases affecting the face and hands-crucial for non-verbal communication and social interaction-can deeply impact psychological well-being. Beyond physical symptoms, their visibility often affec...
HER2 inhibitors in the management of HER2-positive extramammary Paget's disease: a literature review [0.03%]
HER2抑制剂在HER2阳性额外乳腺佩吉特病治疗中的应用：文献综述
M Piroth,F Gohard,J Eugène-Lamer et al.
M Piroth et al.
Extramammary Paget's disease (EMPD) is a rare malignant adenocarcinoma with a poor prognosis when invasive or metastatic, and no standardized care when inoperable. One-third of EMPDs overexpress HER2/ERBB2 (human epidermal growth factor rec...
Efficacy and safety of anti-PD-1 plus lenvatinib in mucosal melanoma: a real-world series [0.03%]
抗PD-1联合仑伐替尼治疗黏膜黑色素瘤的疗效和安全性：真实世界系列研究
S Tzoumpa,C Bejar,A Khammari et al.
S Tzoumpa et al.